wegovy is tirzepatide Weight loss drugs like Mounjaro (Tirzepatide) and (Semaglutide) are changing the way we approach obesity management. But patients often ask: ✔️ How do these medicines work? ✔️ Who should use them Can you switch from Wegovy

Third-Party Test Results (Certificate of Analysis)

13.7% average weight loss with semaglutide

Evidence synthesis: We integrate RCT evidence on weight and metabolic outcomes with exploratory findings on reproductive outcomes, highlighting key effect modifiers (baseline obesity/IR phenotype, concomitant metformin, and follow-up window)

Posology and Method of Administration: The starting dose is 0.25 mg once a week for the first 4 weeks

Although these levels fluctuate throughout the day, they are most impacted by food and how often we eat

doi: 10.3390/nu10030297 120 BabbsRKSunXFelstedJChouinard-DecorteFVeldhuizenMGSmallDM